An EFS - Early Feasibility Study - would be a small number:
So sayeth the FDA
A Pivotal study for a Medical Device would be analogous to a Phase-3 drug trial. Just what size patient cohort would be required I couldn't say.
My mug's eye view would be that 500 would be the low end of a Pivotal Study.
Informed opinions about plausible sequences to commercialsation welcomed.
P
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-33
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.00 |
Change
-0.400(3.85%) |
Mkt cap ! $219.8M | |||
| Open | High | Low | Value | Volume |
| $10.57 | $10.59 | $9.90 | $99.47K | 9.611K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 745 | $10.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.17 | 568 | 3 |
View Market Depth
| Last trade - 13.00pm 07/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |